Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

The treatment showed an objective response rate of 44% and a disease control rate of 94%. ・Kura said tumor shrinkage was seen in 75% of the 16 patients on trial. ・The results were presented at the ...

By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer drug Mo-rez has ...

The Merck update, which will shed light on a $588 million bet to succeed Keytruda, is part of a roster of presentations that ...

Researchers have found a link between healthier diets containing fruits, vegetables, and whole grains and higher rates of ...

Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers ...

As recognized leaders in cancer research, Huntsman Cancer Institute physicians and scientists are utilizing artificial intelligence (AI) to accelerate discoveries and improve patient care. When I was ...

Researchers comparing maps of CAFOs with county-level disease data from California, Texas and Iowa found increased rates of ...

Adults with acromegaly may have increased risk for some cancers compared with the general population, according to data from ...

Cancer rates in Canada will remain high in 2026. Lung, breast, prostate, and colorectal cancers will be the most common, ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. This voice experience is generated by AI. Learn more. This voice ...